Jazz Pharmaceuticals plc’s filing revealed that its SVP, Chief Accounting Officer Carr Patricia unloaded Company’s shares for reported $0.21 million on Mar 07 ’24. In the deal valued at $116.98 per share,1,768 shares were sold. As a result of this transaction, Carr Patricia now holds 6,596 shares worth roughly $0.73 million.
Then, Carr Patricia sold 1,936 shares, generating $231,628 in total proceeds. Upon selling the shares at $119.64, the SVP, Chief Accounting Officer now owns 8,364 shares.
Before that, Johnson Philip L bought 12,000 shares. Jazz Pharmaceuticals plc shares valued at $1,435,800 were divested by the EVP & Chief Financial Officer at a price of $119.65 per share. As a result of the transaction, Johnson Philip L now holds 27,932 shares, worth roughly $3.1 million.
Robert W. Baird initiated its Jazz Pharmaceuticals plc [JAZZ] rating to an Outperform in a research note published on January 03, 2024; the price target was $160. A number of analysts have revised their coverage, including UBS’s analysts, who decreased its forecast for the stock in late November from “a Buy” to “a Neutral”. Raymond James began covering JAZZ with “Mkt perform” recommendation on September 29, 2023.
Price Performance Review of JAZZ
On Monday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock jump 0.30% to $110.91. Over the last five days, the stock has lost -3.63%. Jazz Pharmaceuticals plc shares have fallen nearly -9.83% since the year began. Nevertheless, the stocks have fallen -23.91% over the past one year. While a 52-week high of $147.14 was reached on 02/26/24, a 52-week low of $110.42 was recorded on 04/15/24. SMA at 50 days reached $120.94, while 200 days put it at $126.20. A total of 0.58 million shares were traded, compared to the trading of 0.63 million shares in the previous session.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 109.91, which if violated will result in even more drops to 108.90. On the upside, there is a resistance level at 112.09. A further resistance level may holdings at 113.27. The Relative Strength Index (RSI) on the 14-day chart is 31.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.79%. Stochastics %K at 5.53% indicates the stock is a buying.
